Aim: Whole-breast radiation therapy after breast-conserving surgery can control local recurrence with a long-term survival rate equivalent to that of radical mastectomy for patients with early breast cancer. However, the significance of radiation therapy for patients with positive/close margins after mastectomy remains controversial. Following radical mastectomy, no residual breast parenchyma remains, and thus radiation therapy of the entire chest wall may represent overtreatment in the patients, especially those without lymph node metastasis (N0). We therefore implemented partial chest wall radiation therapy for patients with N0 breast cancer and positive and/or close margins after mastectomy.
INTRODUCTION
Following breast-conserving surgery for breast cancer, a positive surgical margin is widely recognized to increase the risk of local recurrence by at least twofold compared with a negative margin. [1] [2] [3] For patients with positive margins after breast-conserving surgery, This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. the National Comprehensive Cancer Network guidelines and other guidelines recommend re-excision to ensure that the margins are indeed negative. [4] [5] [6] One report has indicated that re-excision resulted in the detection of residual tumors in 24% to 84% of patients according to the extent of positive margins after breast-conserving surgery. 7 The above-mentioned guidelines recommend that re-excision should also be performed to secure negative margins in patients with positive margins after mastectomy. 6 Re-excision after mastectomy, however, is invasive and frequently difficult to perform because it requires the excision of muscle and ribs in addition to the mammary tissue already removed. Re-excision of the skin may occasionally be performed if a positive margin is detected after nipple-sparing mastectomy (NSM).
Furthermore, re-excision increases the risk of complications such as postoperative infection and may delay the initiation of subsequent adjuvant chemotherapy. 8, 9 Thus, for patients with positive or "close" margins after breast-conserving surgery, boost irradiation to the primary tumor bed is often added to whole-breast radiation therapy (WBRT). Some reports indicate that additional irradiation can decrease the local recurrence rate in patients with positive/close margins to a rate as low as that in patients with negative margins, whereas other reports indicate that the recurrence rate, even after additional irradiation, remains higher than that in patients with negative margins. [10] [11] [12] Moreover, in patients with positive/close margins after mastectomy, including those with axillary lymph node metastasis, postmastectomy RT (PMRT) of the chest wall or regional lymph nodes has widely been recognized to reduce the local recurrence rate and has become standard treatment. 13, 14 Because the number of patients with positive/close margins without axillary lymph node metastasis after mastectomy is small, however, the significance of PMRT in this patient population is unknown. No recommendations have been offered, even in the American Society of Clinical Oncology guidelines. 15 In the electron intraoperative therapy (ELIOT) study, NSM was combined with intraoperative RT with electrons as a strategy for partial chest wall RT (PCWRT), although patients with positive margins were excluded from the study population. 16 We performed PCWRT in patients with positive/close margins and no pathological evidence of axillary lymph node metastasis and compared the outcomes with those of patients who did not undergo re-excision or PCWRT. Informed consent was obtained from all patients.
PATIENTS AND METHODS

Surgical margin status
As is the case after breast-conserving surgery, a positive margin was defined as an invasive carcinoma or a ductal carcinoma in situ (DCIS) microscopically identified ink on tumor tissue (defined as abnormal tissue just touching the ink). 6 A close margin was defined as having a tumor ≤1 mm from the inked resection edge. This definition F I G U R E 1 Representative digitally reconstructed radiograph for partial chest wall radiation therapy. The primary tumor bed (red) and clinical target volume (light red) were contoured. The cephalocaudal length was 12 cm, and did not include the entire chest wall [Colour figure can be viewed at wileyonlinelibrary.com] relied on a shorter distance than that previously accepted (≤10 mm or ≤2 mm). 17,18
Nuclear grading
Severity was classified according to a three-point scale (grades 1-3)
based on a composite picture of nuclear atypia and mitotic counts on hematoxylin and eosin-stained carcinomatous tissue specimens.
Immunohistological subtypes
Estrogen receptors (ERs) and human epidermal growth factor receptor 2 (HER2) were evaluated by immunohistochemistry (IHC) analysis.
HER2 was judged positive when the IHC score was 3+ or there was a positive fluorescence in situ hybridization test result. The Ki-67 antibody MIB-1 clone (Dako, Glostrup, Denmark) was used to detect Ki-67 expression. The Ki-67 proliferation index was defined as the percentage of cells with positive nuclear Ki-67 immunostaining in a section of confirmed carcinomatous tissue.
PCWRT parameters
The primary tumor bed was contoured by reference to preoperative computed tomography or magnetic resonance imaging, or to a pathological specimen. The clinical target volume (CTV) was defined as the primary tumor bed plus a margin of at least 2 cm with clipping patient and muscle surface and fat. For example, three-dimensional (3D) conformal RT (CRT) consisting of two tangential beams was planned for the CTV. The field size was set as the partial chest wall measuring ≥9.5 cm in the cephalocaudal dimension ( Figure 1 ). Using the thickness of the chest wall as the basis, irradiation of 4-to 10-MV photons or 5to 8-MeV electrons with or without a bolus to the skin was planned, and 95% of the prescribed isodose volume was used to irradiate the CTV to the maximum extent.
Statistical methods
SPSS version 21.0 (IBM, Armonk, NY, USA) was used for statistical analysis. Clinicopathological characteristics were compared between groups with and without PCWRT using Pearson's 2 test. Table 1 
RESULTS
DISCUSSION
Some patients with breast cancer who undergo a mastectomy are node-negative, and understandably, there may be a reluctance to recommend RT of the entire chest wall. Previous studies have shown that patient characteristics can vary in terms of margin status, presence of axillary lymph node metastasis, and use of PMRT ( Table 2 ). The association between margin status and local recurrence after mastectomy without PMRT was investigated in two studies conducted during the 1980s. Both studies addressed the association between the posterior margin (the distance from the tumor margin to the pectoral fascia) and local recurrence. 20, 21 One of the studies included patients with axillary lymph node metastasis, 20 and the other focused on patients without axillary lymph node metastasis. 21 Neither study showed any correlation between the distance from the tumor to the posterior margin and local recurrence. In a study that included patients with axillary lymph node metastasis who did not undergo PMRT, the presence of positive/close margins (<5 mm) after postoperative chemotherapy was associated with an increased risk of locoregional recurrence. 22 In another study in patients at pathological stage T1-2 without axillary lymph node metastasis and who did not undergo PMRT, the local recurrence rate was extremely low (1.68%). The study protocol, however, excluded patients with positive margins from the analysis. 23 In a study involving patients at pathological stage T3 without axillary lymph node metastasis who did not undergo PMRT, the locoregional recurrence rate was 7.1%. Cancer recurred on the chest wall in 85.7% of the patients with recurrence, but the surgical margins were not examined. 24 In a study conducted in patients aged ≤50 years with positive/close margins (≤6 mm) who did not undergo PMRT, including those with axillary lymph node metastasis, the local recurrence rate was high (23%), indicating that younger patients with positive/close margins might benefit more from PMRT than older patients. 17 In studies conducted in high-risk patients, such as those with tumors ≥5 cm who underwent PMRT and those with invasion of the skin or fascia, the locoregional recurrence rate decreased from 17%-23% to 3%-6% after PMRT was performed along with chemotherapy or hormone therapy, even in patients without axillary lymph node metastasis. However, the surgical margins were not examined in these studies. 25, 26 In a study involving patients at pathological stage T3 without axillary lymph node metastasis after PMRT and who were selected from the U.S. National
Cancer Data Base, PMRT was shown to improve outcomes, regardless of whether the margins were positive or negative. 27 In that study, the RT field was also analyzed, and regional lymph node area irradiation in combination with chest wall RT was not associated with the outcomes.
In a study conducted in patients with positive/close margins (≤2 mm),
including those with axillary lymph node metastasis after PMRT, the presence of positive/close margins did not correlate with locoregional recurrence when a 15 or 20 Gy boost dose was delivered to the tumor bed in addition to PMRT. 18 Regarding the site of local recurrence, some reports have shown that the cancer recurred in the surgical field in 33% to 67% of patients after breast-conserving surgery. 28, 29 For partial breast irradiation, which has recently been implemented based on these reports, the CTV is defined as an area covering the tumor bed cavity and at least 1 cm of surrounding mammary gland. 30 In patients who have undergone mastectomy, however, the CTV for RT is difficult to establish because the surrounding mammary gland has been removed. Local chest wall recurrence after mastectomy has reportedly been detected within 7 cm of the inferior margin of the operation's transverse scar in ≥97% of patients. 31 In our patients, who did not have risk factors (eg, axillary lymph node metastasis) other than positive/close margins, the RT field was not expanded to cover the entire chest wall in a uniform manner. Instead, we selected PCWRT with a field having at least 2-cm margins to the primary tumor bed and measuring ≥9.5 cm in the cephalocaudal dimension. In all previous studies of PMRT, the RT field was all of the chest wall with or without the regional lymph node area. To the best of our knowledge, the current study is the first to report the selection of only part of the chest wall for PMRT. Regarding the sites of positivity on the margin, one study showed that the proportion of patients with residual tumor did not correlate with the presence of four positive mammary gland margin directions (medial, lateral, superior, and inferior) or the presence of two nonmammary gland margin directions (anterior and posterior) in patients undergoing breast-conserving surgery. 32 Another study showed that positive nonmammary gland margins are associated with a significantly lower local recurrence rate than positive peripheral mammary gland margins, suggesting that subcutaneous and retromammary fat should be retained during breast-conserving surgery. 33 In the present study, the absence of local recurrence might have been attributable to the fact that all patients had undergone mastectomy and had positive/close nonbreast parenchymal margins.
RT doses, which have been investigated in patients with positive/close margins (≤2 mm), showed no correlation between the margin status and locoregional recurrence when a 15-or 20-Gy boost dose was delivered to the tumor bed in addition to PMRT at 50 Gy. 18 Another study showed that when patients with positive margins after breastconserving surgery received a 10-or 26-Gy boost dose in addition to WBRT at 50 Gy, there was no difference in the local recurrence rate in the two groups. 34 After evaluating the results of these studies, we irradiated only part of the chest wall with a total dose of 50-66 Gy in the present study and achieved good local control. However, local control was also satisfactory in patients without irradiation, and therefore the significance of PCWRT remains unclear. In the present study, the baseline characteristics varied between the two groups.
For example, the PCWRT group included significantly more patients with positive margins. When the breast parenchyma was removed by mastectomy, locoregional control might have been more strongly affected by the presence or absence of lymph node metastasis than by the surgical margin status. Limitations of the present study include the relatively short follow-up period. However, during our review of previous studies on patients' undergoing mastectomy for breast cancer, one study investigated any recurrence that developed within 2 years after the procedure, 26 and another showed that locoregional recurrence was detected in 88% of patients within 3 years. 27 Thus, the median follow-up period in the present study may be considered acceptable. In the present study, both the PCWRT group and the no-RT group showed equally good local control without re-excision.
We therefore suggest that PCWRT be considered for patients with node-negative breast cancer after mastectomy if they have positive or close margins, although further studies are required to verify these results.
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